Recent events
Recent events tied to this brand in public sources.
Back to profile7 entries
2022
IBM announces sale of Watson Health assets
IBM announced an agreement to sell healthcare data and analytics assets from its Watson Health business to Francisco Partners. The transaction was expected to close in the second quarter of 2022.
2022
IBM agrees to sell Watson Health data and analytics business
IBM agreed to sell Watson Health's data and analytics business to Francisco Partners. The transaction was expected to close in the second half of 2022.
2022
IBM announces sale of Watson Health assets to Francisco Partners
IBM announced that it is selling software products and other assets from its Watson Health business to Francisco Partners. The assets include Health Insights, medical imaging software, several product lines and MarketScan datasets; the parties expected to complete the acquisition in the second quarter.
2021
Follett sells School Solutions division to Francisco Partners
Follett Corp. sold its K–12 content and software division, Follett School Solutions, to private investment firm Francisco Partners. Follett Higher Education Group remained part of Follett Corp.
2021
Dell announces proposed sale of Boomi to Francisco Partners and TPG Capital
Dell announced that Francisco Partners and TPG Capital would acquire its Boomi integration-platform business for $4 billion. Dell said it expected the sale to be completed by year-end; the source does not provide a calendar date for the announcement.
2021
News Break completes $115 million Series C funding
News Break announced that it completed a $115 million Series C funding round on January 7. Francisco Partners led the round, and existing investor IDG Capital also participated.
2019
LogMeIn agrees to $4.3 billion acquisition
LogMeIn announced that it had agreed to be acquired for $4.3 billion by affiliates of Francisco Partners and Evergreen Coast Capital Corporation. The deal was expected to close in mid-2020, subject to a 45-day go-shop provision and regulatory scrutiny.